comparemela.com

Page 7 - Ch Novn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Get In on This Skin Disease Drug Before Big Pharma Does

Biotech MoonLake Immunotherapeutics is developing a drug that has shown great promise for inflammatory skin conditions

David wainerDow jones company incAll rightsWsjfinance marketsHealthcare life sciencesNorth americaUnited statesRegulation government policyFinancial performanceSales figuresCorporate industrial newsAutoimmune diseasesPolitical general newsMedical conditionsContent typesFactiva filters

Novartis Hikes Profit Guidance, Launches $15 Billion Share Buyback

The board also endorsed plans to spin off its generic medicines unit Sandoz early in the fourth quarter, subject to shareholder approval.

Stefan wermuth bloombergCallum keownArticle normalHealthcare life sciencesFinancial performanceEarnings projectionsCorporate fundingShare capitalOwnership changesAcquisitions mergers shareholdingsCorporate actionsCorporate industrial newsShare buybacks redemptionsContent typesFactiva filtersC amp ampe industry news filter

Novartis AG 2Q Sales $13 6B

By Cecilia Butini Novartis on Tuesday raised its full-year guidance based on a strong first half, and said it is starting a share buyback for up to $15.

Cecilia butiniArticle normalHealthcare life sciencesFinancial performanceSales figuresCorporate fundingShare capitalOwnership changesAcquisitions mergers shareholdingsCorporate actionsCorporate industrial newsShare buybacks redemptionsContent typesFactiva filtersC amp ampe industry news filterNovn eb

Bank of America, Morgan Stanley, Lockheed, Masimo, Novartis, and More Market Movers

Bank of America, Morgan Stanley, Charles Schwab, and Lockheed Martin are among companies scheduled to report earnings Tuesday. Novartis rises after boosting.

United statesMorgan stanleyNew york mellonWall streetArticle normalCommercial bankingFinancial investment servicesSecurity brokering dealingDiversified holding companiesHealthcare life sciencesAerospace defenseBusiness consumer servicesBanking creditFreight transport logisticsDefense equipment productsFinancial services

Novartis Raises 2023 View

By Cecilia Butini Novartis on Tuesday raised its full-year guidance based on a strong first half, and said it is starting a share buyback for up to $15.

Cecilia butiniArticle normalHealthcare life sciencesCorporate fundingShare capitalOwnership changesAcquisitions mergers shareholdingsCorporate actionsCorporate industrial newsShare buybacks redemptionsContent typesFactiva filtersC amp ampe industry news filterNovn ebCh novnIndustrial news

vimarsana © 2020. All Rights Reserved.